Abstract
Currently affecting 8 million people, mainly in Latin America (endemic area), Chagas Disease (CD) is caused by the protozoan Tryoanosoma cruzi (T. cruzi). The 2 medicines (Benznidazole and Nifurtimox) avaliable to treat CD focus on killing the parasite and are partially effective only in the acute phase of the disease. Based on this, new targets and therapies are needed. It was recently d…